MetaVia, Inc. (MTVA)
1.90
-0.32
(-14.41%)
USD |
NASDAQ |
Jun 09, 16:00
1.865
-0.04
(-1.84%)
After-Hours: 20:00
MetaVia EPS Diluted (Quarterly) : -0.7867 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Tonix Pharmaceuticals Holding Corp. | -2.932 |
| UroGen Pharma Ltd. | -0.4698 |
| Relay Therapeutics, Inc. | -0.4075 |
| Aktis Oncology, Inc. | -0.3315 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.823M |
| Total Expenses (Quarterly) | 3.823M |
| Enterprise Value | -2.072M |
| Earnings Yield | -316.8% |
| Normalized Earnings Yield | -321.53 |